AG Schoppmann: Publikationen (seit 2000)

2011

  • Ba-Ssalamah, A., W. Matzek, S. Baroud, N. Bastati, J. Zacherl, S.F. Schoppmann, M. Hejna, F. Wrba, M. Weber, C.J. Herold, and R.M. Gore,  Accuracy of hydro-multidetector row CT in the local T staging of oesophageal cancer compared to postoperative histopathological results. European radiology, 2011. 21(11): p. 2326-35.
  • Birner, P., B. Jesch, J. Friedrich, M. Riegler, J. Zacherl, M. Hejna, F. Wrba, A. Schultheis, and S.F. Schoppmann,  Carbonic anhydrase IX overexpression is associated with diminished prognosis in esophageal cancer and correlates with Her-2 expression. Annals of surgical oncology, 2011. 18(12): p. 3330-7.
  • Birner, P., B. Jesch, J. Friedrich, A. Schultheis, and S.F. Schoppmann,  RAF-kinase inhibitor protein (RKIP) downregulation in esophageal cancer and its metastases. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2011. in revision.
  • Birner, P., B. Jesch, and S.F. Schoppmann,  Her-2 in carcinomas of the esophagus and its metastases. Virchows Archiv, 2011. 459: p. S15-S15.
  • Birner, P. and S.F. Schoppmann,  Her-2 in gastroesophageal cancer: pathobiology, diagnostic and therapeutic implications. European Surgery-Acta Chirurgica Austriaca, 2011. 43(3): p. 162-167.
  • Bojic, M., U. Pluschnig, J. Zacherl, C.M. Thallinger, A. Ba-Ssalamah, J. Maresch, P. Datler, S.F. Schoppmann, and M. Hejna,  Docetaxel, cisplatin and 5-fluorouracil plus granulocyte colony-stimulating factor prophylaxis in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction: experience at the Medical University of Vienna. Anticancer research, 2011. 31(6): p. 2379-82.
  • Maresch, J., S.F. Schoppmann, C.M. Thallinger, C.C. Zielinski, and M. Hejna,  Her-2/neu gene amplification and over-expression in stomach and esophageal adenocarcinoma: From pathology to treatment. Critical reviews in oncology/hematology, 2011.
  • Pertl, L., J. Zacherl, G. Mancusi, J.N. Gachter, R. Asari, S. Schoppmann, W. Bigenzahn, and B. Schneider-Stickler,  High risk of unilateral recurrent laryngeal nerve paralysis after esophagectomy using cervical anastomosis. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies, 2011. 268(11): p. 1605-10.
  • Schoppmann, A., D. Tamandl, B. Herberger, F. Laengle, P. Birner, S. Geleff, T. Gruenberger, and S.F. Schoppmann,  Comparison of Lymphangiogenesis between Primary Colorectal Cancer and Corresponding Liver Metastases. Anticancer research, 2011. in press.
  • Schoppmann, S.F., E. Bareck, F. Laengle, and J. Zacherl, Gastrointestinale Stromatumoren (GIST), in ACO-ASSO Manual 3.Auflage 2011, D. Kandioler, Editor 2011: Vienna.
  • Schoppmann, S.F., B. Jesch, J. Zacherl, F. Wrba, M. Hejna, J. Maresch, F.B. Langer, M.F. Riegler, U. Pluschnig, and P. Birner,  HER-2 status in primary oesophageal cancer, lymph nodes and distant metastases. The British journal of surgery, 2011. 98(10): p. 1408-13.
  • Schoppmann, S.F., E. Wenzl, and J. Zacherl, Ösophaguskarzinom, in ACO-ASSO Manual 3. Auflage 2011, D. Kandioler, Editor 2011: Vienna.
  • Starlinger, P., L. Alidzanovic, D. Schauer, P. Brugger, S. Sommerfeldt, I. Kuehrer, S.F. Schoppmann, M. Gnant, and C. Brostjan,  Platelet-stored angiogenesis factors: clinical monitoring is prone to artifacts. Disease markers, 2011. 31(2): p. 55-65.
  • Starlinger, P., P. Brugger, C. Reiter, D. Schauer, S. Sommerfeldt, D. Tamandl, I. Kuehrer, S.F. Schoppmann, M. Gnant, and C. Brostjan,  Discrimination between circulating endothelial cells and blood cell populations with overlapping phenotype reveals distinct regulation and predictive potential in cancer therapy. Neoplasia, 2011. 13(10): p. 980-90.
  • Starlinger, P., P. Brugger, D. Schauer, S. Sommerfeldt, D. Tamandl, I. Kuehrer, S.F. Schoppmann, M. Gnant, and C. Brostjan,  Myelosuppression of thrombocytes and monocytes is associated with a lack of synergy between chemotherapy and anti-VEGF treatment. Neoplasia, 2011. 13(5): p. 419-27.
  • Zacherl, J., S.F. Schoppmann, A. Ba-SSalamah, U. Pluschnig, M. Hejna, and F. Wrba, Magenkarzinom, in ACO-ASSO Manual 3. Auflage 2011, D. Kandioler, Editor 2011: Vienna.
  • Fischer, S., S.F. Schoppmann, F.M. Riegler, and J. Zacherl, Radiofrequenz ablation and antireflux management for non-dysplastic Barrett’s esophagus, L. Bonavina, Editor 2012. In press

2010

  • Langer, F.B., A. Bohdjalian, S. Shakeri-Leidenmuhler, S.F. Schoppmann, J. Zacherl, and G. Prager,  Conversion from sleeve gastrectomy to Roux-en-Y gastric bypass–indications and outcome. Obesity surgery, 2010. 20(7): p. 835-40.
  • Langer, F.B., S.F. Schoppmann, G. Prager, F.M. Riegler, and J. Zacherl,  Solving the problem of difficult stent removal due to tissue ingrowth in partially uncovered esophageal self-expanding metal stents. The Annals of thoracic surgery, 2010. 89(5): p. 1691-2.
  • Langer, F.B., S.F. Schoppmann, G. Prager, F. Tomaselli, U. Pluschnig, M. Hejna, R. Schmid, and J. Zacherl,  Temporary placement of self-expanding oesophageal stents as bridging for neo-adjuvant therapy. Annals of surgical oncology, 2010. 17(2): p. 470-5.
  • Langer, F.B., S. Shakeri-Leidenmuhler, A. Bohdjalian, S. Schoppmann, J. Zacherl, F.X. Felberbauer, G. Vila, and G. Prager,  Strategies for weight regain after sleeve gastrectomy. Surgical laparoscopy, endoscopy & percutaneous techniques, 2010. 20(3): p. 159-61.
  • Panhofer, P., B. Izay, K. Schwameis, S. Schoppmann, G. Prager, R. Jakesz, F.M. Riegler, and J. Zacherl,  Gastrointestinal reconstructions in 1200 patients with cancer at the pharyngesophageal junction. European Surgery-Acta Chirurgica Austriaca, 2010. 42(1): p. 38-48.
  • Schoppmann, S.F.,  Lymphangiogenese und Metastasierung. krebs:hilfe, 2010. 1/10.
  • Schoppmann, S.F., B. Jesch, J. Friedrich, F. Wrba, A. Schultheis, U. Pluschnig, J. Maresch, J. Zacherl, M. Hejna, and P. Birner,  Expression of Her-2 in carcinomas of the esophagus. The American journal of surgical pathology, 2010. 34(12): p. 1868-73.
  • Schoppmann, S.F., G. Prager, F.B. Langer, F.M. Riegler, B. Kabon, E. Fleischmann, and J. Zacherl,  Open versus minimally invasive esophagectomy: a single-center case controlled study. Surgical endoscopy, 2010. 24(12): p. 3044-53.
  • Schoppmann, S.F., D. Tamandl, L. Roberts, G. Jomrich, A. Schoppmann, R. Zwrtek, P. Dubsky, M. Gnant, R. Jakesz, and P. Birner,  HER2/neu expression correlates with vascular endothelial growth factor-C and lymphangiogenesis in lymph node-positive breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 2010. 21(5): p. 955-60.
  • Schoppmann, S.F., K. Thomanek, M. Gnant, and R. Jakesz, The Austrian Breast and Colorectal Cancer Study Group Experience, in Kuerer’s Breast Surgical Oncology, H.M. Kuerer, Editor 2010, Mc Graw Hill Medical: Houston. p. 561-569.
  • Starlinger, P., H.P. Moll, A. Assinger, C. Nemeth, K. Hoetzenecker, B. Gruenberger, T. Gruenberger, I. Kuehrer, S.F. Schoppmann, M. Gnant, and C. Brostjan,  Thrombospondin-1: a unique marker to identify in vitro platelet activation when monitoring in vivo processes. Journal of thrombosis and haemostasis : JTH, 2010. 8(8): p. 1809-19.

2009

  • Blaha, P., R. Exner, A.D. Borgo, S. Bigenzahn, P. Panhofer, O. Riedl, S. Schoppmann, T. Bachleitner-Hofmann, E. Sporn, U. Pluschnig, F. Fitzal, G. Steger, R. Jakesz, P. Dubsky, and M. Gnant,  Is Endocrine Therapy Really Pleasant? Considerations about the Long-Term Use of Antihormonal Therapy and Its Benefit/Side Effect Ratio. Breast Care, 2009. 4(3): p. 155-161.
  • Gnant, M., P. Dubsky, F. Fitzal, P. Blaha, S. Schoppmann, G. Steger, C. Marth, H. Samonigg, K. Huttner, H. Fohler, E. Ruecklinger, R. Jakesz, and R. Greil,  Maintaining bone density in patients undergoing treatment for breast cancer: is there an adjuvant benefit? Clinical Breast Cancer, 2009. 9 Suppl 1: p. S18-27.
  • Gnant, M., B. Mlineritsch, W. Schippinger, G. Luschin-Ebengreuth, S. Postlberger, C. Menzel, R. Jakesz, M. Seifert, M. Hubalek, V. Bjelic-Radisic, H. Samonigg, C. Tausch, H. Eidtmann, G. Steger, W. Kwasny, P. Dubsky, M. Fridrik, F. Fitzal, M. Stierer, E. Rucklinger, R. Greil, and C. Marth,  Endocrine therapy plus zoledronic acid in premenopausal breast cancer. The New England journal of medicine, 2009. 360(7): p. 679-91. (Collaborator)
  • Schoppmann, S.F., E. Bareck, F. Laengle, and J. Zacherl,  Gastrointestinale Stromatumoren. Journal für Gastroenterologische und Hepatologische Erkrankungen, 2009. 7(4): p. 45-52.
  • Schoppmann, S.F., G. Prager, F. Langer, M. Riegler, E. Fleischman, and J. Zacherl,  Fifty-five minimally invasive Esophagectomies: a single centre experience. Anticancer research, 2009. 29(7): p. 2719-25.
  • Silberhumer, G.R., G. Gyori, C. Burghuber, C. Neumayer, M. Riegler, R. Jakesz, G. Prager, S.F. Schoppmann, and J. Zacherl,  The value of protecting the longitudinal staple line with invaginating sutures during esophageal reconstruction by gastric tube pull-up. Digestive surgery, 2009. 26(4): p. 337-41.
  • Silberhumer, G.R., M. Hufschmid, F. Wrba, G. Gyoeri, S. Schoppmann, B. Tribl, E. Wenzl, G. Prager, F. Laengle, and J. Zacherl,  Surgery for gastrointestinal stromal tumors of the stomach. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2009. 13(7): p. 1213-9.

2008

  • Gnant, M., B. Mlineritsch, G. Luschin-Ebengreuth, F. Kainberger, H. Kassmann, J.C. Piswanger-Solkner, M. Seifert, F. Ploner, C. Menzel, P. Dubsky, F. Fitzal, V. Bjelic-Radisic, G. Steger, R. Greil, C. Marth, E. Kubista, H. Samonigg, P. Wohlmuth, M. Mittlbock, and R. Jakesz,  Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy. The lancet oncology, 2008. 9(9): p. 840-9. (Collaborator)
  • Gnant, M., S. Schoppmann, I. Kuehrer, P. Goetzinger, K. Sahora, S. Kandutsch, F. Wrba, C. Brostjan, P. Goetzinger, K. Turetschek, C. Zielinski, B. Teleky, J. Fried, A. Stift, and R. Jakesz,  Bevacizumab plus gemcitabine for the neoadjuvant treatment of locally advanced non-metastatic pancreatic cancer. Annals of Oncology, 2008. 19: p. 70-71.

    Kappel, S., C. Bichler, B. Wolf, S. Gacic, S.F. Schoppmann, Y. Devyatko, G. Prager, A. Ba-SSalamah, F. Wrba, U. Pluschnig, I. Kuhrer, M. Mittlbock, M. Hejna, J. Zacherl, D. Kandioler, and P.S. Grp,  Ein Umbruch in der chirurgischen Onkologie: Hintergrunde der aEuro cent Pancho Studie. European Surgery-Acta Chirurgica Austriaca, 2008. 40(6): p. 277-283.

  • Mlineritsch, B., C. Tausch, C. Singer, G. Luschin-Ebengreuth, R. Jakesz, F. Ploner, M. Stierer, E. Melbinger, C. Menzel, A. Urbania, M. Fridrik, G. Steger, P. Wohlmuth, M. Gnant, and R. Greil,  Exemestane as primary systemic treatment for hormone receptor positive post-menopausal breast cancer patients: a phase II trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-17). Breast cancer research and treatment, 2008. 112(1): p. 203-13. (Collaborator)
  • Schoppmann, S.F., Epidemiologie und Pathogenese von Kolorektalen Lebermetastasen, in Therapiemanagement von Lebermetastasen bei Gastrointestinalen Tumoren, T. Gruenberger, Editor 2008, Uni-Med: Bremen-London-Boston.
  • Tamandl, D., B. Herberger, B. Gruenberger, S.F. Schoppmann, H. Puhalla, M. Schindl, W. Schima, R. Jakesz, and T. Gruenberger,  Adequate preoperative staging rarely leads to a change of intraoperative strategy in patients undergoing surgery for colorectal cancer liver metastases. Surgery, 2008. 143(5): p. 648-57.

2007

  • Schima, W., S.F. Schoppmann, and G. Prager,  Aktuelle Bilder: Akutes Abdomen nach laparoskopischer Cholezystektomie. Journal für Gastroenterologische und Hepatologische Erkrankungen, 2007. 5(3): p. 20.
  • Schindl, M., M. Gnant, S.F. Schoppmann, R. Horvat, and P. Birner,  Overexpression of the human homologue for Caenorhabditis elegans cul-4 gene is associated with poor outcome in node-negative breast cancer. Anticancer research, 2007. 27(2): p. 949-52.
  • Schoppmann, S.F., D. Kandioler, and R. Horvat, Operative Verfahren beim DCIS, in Mammakarzinom: Operative Behandlungskonzepte, R. Jakesz, Editor 2007, Springer: Vienna. p. 51-61.
  • Tamandl, D., B. Gruenberger, B. Herberger, S. Schoppmann, M. Bodingbauer, M. Schindl, H. Puhalla, E. Fleischmann, W. Schima, R. Jakesz, F. Laengle, and T. Gruenberger,  Selective resection of colorectal liver metastases. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2007. 33(2): p. 174-82.

2006

  • Bachleitner-Hofmann, T., M. Strohschneider, P. Krieger, M. Sachet, P. Dubsky, H. Hayden, S.F. Schoppmann, R. Pfragner, M. Gnant, J. Friedl, and A. Stift,  Heat shock treatment of tumor lysate-pulsed dendritic cells enhances their capacity to elicit antitumor T cell responses against medullary thyroid carcinoma. The Journal of clinical endocrinology and metabolism, 2006. 91(11): p. 4571-7.
  • S.F. Schoppmann,  Fenzl, A., , S. Geleff, P. Birner, F. Wrba, B. Herberger, B. Teleky, F. Herbst, I. Kuehrer, R. Jakesz, and F. Laengle,  Vascular endothelial growth factor-C expression and lymphangiogenesis in colorectal cancer. European Surgery-Acta Chirurgica Austriaca, 2006. 38: p. 149-154.
  • Schoppmann, S., A. Fenzl, D. Tamandl, M. Bodingbauer, M. Schindl, H. Puhalla, B. Grunberger, B. Teleky, T. Grunberger, and F. Langle,  Impact of lymphangiogenesis in colorectal liver metastases. Annals of Oncology, 2006. 17: p. 33-33.
  • Schoppmann, S.F., A. Fenzl, K. Nagy, S. Unger, G. Bayer, S. Geleff, M. Gnant, R. Horvat, R. Jakesz, and P. Birner,  VEGF-C expressing tumor-associated macrophages in lymph node positive breast cancer: impact on lymphangiogenesis and survival. Surgery, 2006. 139(6): p. 839-46.
  • Schoppmann, S.F., A. Fenzl, M. Schindl, T. Bachleitner-Hofmann, K. Nagy, M. Gnant, R. Horvat, R. Jakesz, and P. Birner,  Hypoxia inducible factor-1alpha correlates with VEGF-C expression and lymphangiogenesis in breast cancer. Breast cancer research and treatment, 2006. 99(2): p. 135-41.
  • Schoppmann, S.F. and R. Jakesz,  Early-stage breast cancer – Highlights at ASCO 2006. Breast Care, 2006. 1(4): p. 265-269.
  • Tamandl, D., B. Gruenberger, B. Herberger, S. Schoppmann, M. Bodingbauer, E. Fleischmann, W. Schima, R. Jakesz, F. Laengle, and T. Gruenberger,  Safe surgery for colorectal cancer liver metastases using modern dissection techniques. Annals of Oncology, 2006. 17: p. 57-57.

2005

  • Schoppmann, S.F.,  Lymphangiogenesis, inflammation and metastasis. Anticancer research, 2005. 25(6C): p. 4503-11.

2004

  • Schoppmann, S.F., G. Bayer, K. Aumayr, S. Taucher, S. Geleff, M. Rudas, E. Kubista, H. Hausmaninger, H. Samonigg, M. Gnant, R. Jakesz, and R. Horvat,  Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer. Annals of surgery, 2004. 240(2): p. 306-12.
  • Schoppmann, S.F., A. Soleiman, R. Kalt, Y. Okubo, C. Benisch, U. Nagavarapu, G.S. Herron, and S. Geleff,  Telomerase-immortalized lymphatic and blood vessel endothelial cells are functionally stable and retain their lineage specificity. Microcirculation, 2004. 11(3): p. 261-9.
  • Valencak, J., E. Heere-Ress, T. Kopp, S.F. Schoppmann, H. Kittler, and H. Pehamberger,  Selective immunohistochemical staining shows significant prognostic influence of lymphatic and blood vessels in patients with malignant melanoma. European journal of cancer, 2004. 40(3): p. 358-64

2003

  • Geleff, S., S.F. Schoppmann, and G. Oberhuber,  Increase in podoplanin-expressing intestinal lymphatic vessels in inflammatory bowel disease. Virchows Archiv, 2003. 442(3): p. 231-237.
  • Schindl, M., S.F. Schoppmann, T. Strobel, H. Heinzl, C. Leisser, R. Horvat, and P. Birner,  Level of Id-1 protein expression correlates with poor differentiation, enhanced malignant potential, and more aggressive clinical behavior of epithelial ovarian tumors. Clinical cancer research : an official journal of the American Association for Cancer Research, 2003. 9(2): p. 779-85.
  • Schoppmann, S.F., M. Schindl, G. Bayer, K. Aumayr, J. Dienes, R. Horvat, M. Rudas, M. Gnant, R. Jakesz, and P. Birner,  Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer. International journal of cancer. Journal international du cancer, 2003. 104(6): p. 677-82.

2002

  • Schindl, M., S.F. Schoppmann, H. Samonigg, H. Hausmaninger, W. Kwasny, M. Gnant, R. Jakesz, E. Kubista, P. Birner, and G. Oberhuber,  Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2002. 8(6): p. 1831-7.
  • Schoppmann, S.F., P. Birner, J. Stockl, R. Kalt, R. Ullrich, C. Caucig, E. Kriehuber, K. Nagy, K. Alitalo, and D. Kerjaschki,  Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. The American journal of pathology, 2002. 161(3): p. 947-56.
  • Schoppmann, S.F., R. Horvat, and P. Birner,  Lymphatic vessels and lymphangiogenesis in female cancer: mechanisms, clinical impact and possible implications for anti-lymphangiogenic therapies (Review). Oncology reports, 2002. 9(3): p. 455-60.
  • Schoppmann, S.F., R. Horvat, and P. Birner,  Lymphatic vessels and lymphangiogenesis in female cancer: Mechanisms, clinical impact and possible implications for anti-lymphangiogenic therapies (Review). Oncology reports, 2002. 9(3): p. 455-460.
  • Schoppmann, S.F., M. Schindl, and P. Birner, The role of lymphatic vessels in gynecological cancer“ In: R.M. Mohan (Ed., in Research Advances in Cancer, R.M. Mohan, Editor 2002: Kerala. p. 17-21.

2001

  • Kriehuber, E., S. Breiteneder-Geleff, M. Groeger, A. Soleiman, S. Schoppmann, G. Stingl, D. Kerjaschki, and D. Maurer,  Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. Journal of Investigative Dermatology, 2001. 117(6): p. 1680-1680.
  • Kriehuber, E., S. Breiteneder-Geleff, M. Groeger, A. Soleiman, S.F. Schoppmann, G.Stingl, D. Kerjaschki, and D. Maurer,  Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. The Journal of experimental medicine, 2001. 194(6): p. 797-808.
  • Schindl, M., G. Oberhuber, A. Obermair, S.F. Schoppmann, B. Karner, and P. Birner,  Overexpression of Id-1 protein is a marker for unfavorable prognosis in early-stage cervical cancer. Cancer research, 2001. 61(15): p. 5703-6.
  • Schoppmann, S.F., P. Birner, P. Studer, and S. Breiteneder-Geleff,  Lymphatic microvessel density and lymphovascular invasion assessed by anti-podoplanin immunostaining in human breast cancer. Anticancer research, 2001. 21(4A): p. 2351-5.
  • Schoppmann, S.F., M. Schindl, S. Breiteneder-Geleff, A. Soleima, G. Breitenecker, B. Karner, and P. Birner,  Inflammatory stromal reaction correlates with lymphatic microvessel density in early-stage cervival cancer. Anticancer research, 2001. 21(5): p. 3419-23.

2000

  • Schoppmann, S.F., Lymphatic Microvessels in Invasive Breast Cancer, in Department for Pathology, Department of Surgery, 2000, Medical University of Vienna: Vienna. (Thesis)